{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:08:04Z","timestamp":1778954884212,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,16]]},"DOI":"10.7759\/cureus.108980","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:52:20Z","timestamp":1778953940000},"source":"Crossref","is-referenced-by-count":0,"title":["Syndrome of Inappropriate Antidiuretic Hormone Secretion as the Initial Manifestation of Guillain-Barr\u00e9 Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Hema C","family":"Aremanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Torres Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupama","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"326","author":"Ropper AH","year":"1992","unstructured":"Ropper AH. The Guillain-Barr\u00e9 syndrome. N Engl J Med. 1992, 326:1130-6. 10.1056\/NEJM199204233261706","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3205\/000220","article-title":"Guillain-Barr\u00e9 syndrome: clinical profile and management","volume":"13","author":"Sudulagunta SR","year":"2015","unstructured":"Sudulagunta SR, Sodalagunta MB, Sepehrar M, et al.. Guillain-Barr\u00e9 syndrome: clinical profile and management. Ger Med Sci. 2015, 13:Doc16. 10.3205\/000220","journal-title":"Ger Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0542-y","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update","volume":"29","author":"Zaeem Z","year":"2019","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update. Clin Auton Res. 2019, 29:289-99. 10.1007\/s10286-018-0542-y","journal-title":"Clin Auton Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.08.005","article-title":"The morbidity and outcome of patients with Guillain-Barr\u00e9 syndrome admitted to the intensive care unit","volume":"264","author":"Dhar R","year":"2008","unstructured":"Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barr\u00e9 syndrome admitted to the intensive care unit. J Neurol Sci. 2008, 264:121-8. 10.1016\/j.jns.2007.08.005","journal-title":"J Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2024.27","article-title":"Hyponatremia in Guillain-Barre syndrome: a review of its pathophysiology and management","volume":"52","author":"Netto AB","year":"2025","unstructured":"Netto AB, Chandrahasa N, Koshy SS, Taly AB. Hyponatremia in Guillain-Barre syndrome: a review of its pathophysiology and management. Can J Neurol Sci. 2025, 52:9-19. 10.1017\/cjn.2024.27","journal-title":"Can J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226925","article-title":"Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome","volume":"12","author":"Shah PM","year":"2019","unstructured":"Shah PM, Dhakre VW, Veerasuri R, Bhabhor A. Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome. BMJ Case Rep. 2019, 12:e226925. 10.1136\/bcr-2018-226925","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/30445.10662","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barr\u00e9 syndrome","volume":"11","author":"James J","year":"2017","unstructured":"James J, Jose J. Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barr\u00e9 syndrome. J Clin Diagn Res. 2017, 11:OD16-7. 10.7860\/JCDR\/2017\/30445.10662","journal-title":"J Clin Diagn Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67427-6","article-title":"Risk factors and outcome of hyponatremia in patients with Guillain-Barr\u00e9 syndrome","volume":"14","author":"Ogawa S","year":"2024","unstructured":"Ogawa S, Hosokawa T, Hayakawa C, et al.. Risk factors and outcome of hyponatremia in patients with Guillain-Barr\u00e9 syndrome. Sci Rep. 2024, 14:16664. 10.1038\/s41598-024-67427-6","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.729252","article-title":"Sodium levels predict disability at discharge in Guillain-Barr\u00e9 syndrome: a retrospective cohort study","volume":"12","author":"Gagliardi D","year":"2021","unstructured":"Gagliardi D, Faravelli I, Podest\u00e0 MA, et al.. Sodium levels predict disability at discharge in Guillain-Barr\u00e9 syndrome: a retrospective cohort study. Front Neurol. 2021, 12:729252. 10.3389\/fneur.2021.729252","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-018-0122-y","article-title":"Prognostic factors of Guillain-Barr\u00e9 syndrome: a 111-case retrospective review","volume":"4","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Zhao Y, Wang Y. Prognostic factors of Guillain-Barr\u00e9 syndrome: a 111-case retrospective review. Chin Neurosurg J. 2018, 4:14. 10.1186\/s41016-018-0122-y","journal-title":"Chin Neurosurg J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67215","article-title":"Prevalence and prognostic impact of hyponatremia in Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"16","author":"Ekmekyapar F\u0131rat Y","year":"2024","unstructured":"Ekmekyapar F\u0131rat Y, Karaoglu Ak\u0131nc\u0131 Z, Belen BG, T\u00fcrkok CG, Sahin S, Karsidag S. Prevalence and prognostic impact of hyponatremia in Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Cureus. 2024, 16:e67215. 10.7759\/cureus.67215","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1179\/1743132814Y.0000000455","article-title":"Hyponatremia is a predictor for poor outcome in Guillain-Barr\u00e9 syndrome","volume":"37","author":"Wang Y","year":"2015","unstructured":"Wang Y, Liu J. Hyponatremia is a predictor for poor outcome in Guillain-Barr\u00e9 syndrome. Neurol Res. 2015, 37:347-51. 10.1179\/1743132814Y.0000000455","journal-title":"Neurol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn PA","year":"2023","unstructured":"van Doorn PA, Van den Bergh PY, Hadden RD, et al.. European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. Eur J Neurol. 2023, 30:3646-74. 10.1111\/ene.16073","journal-title":"Eur J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461801-syndrome-of-inappropriate-antidiuretic-hormone-secretion-as-the-initial-manifestation-of-guillain-barr-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:52:24Z","timestamp":1778953944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461801-syndrome-of-inappropriate-antidiuretic-hormone-secretion-as-the-initial-manifestation-of-guillain-barr-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.108980","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}